Developing devices that manage higher dose volumes, increased viscosity and larger needle diameters represent engineering challenges that are the subject of a great deal of ongoing research
Spironolactone (10-80 mg/mL, subcutaneous injection) increases pain behavior in a dose-dependent manner in Male Swiss albino mice thermal and electrical pain models, but reduces inflammatory visceral pain caused by intraperitoneal acetic acid and chemical pain caused by plantar capsaicin [3]
Bydureon BCise is an injectable medication taken under the skin
Health Canada requires generics to meet the same safety, efficacy, purity, and bioequivalence standards as the brand
It is available in two formulations: a once-weekly subcutaneous injection (Wegovy for obesity, Ozempic for type 2 diabetes) and a daily oral tablet (Rybelsus for type 2 diabetes)
doi:10.1007/978-94-007-7500-8_8